Literature DB >> 6838022

The effect of corticosteroids on theophylline metabolism.

D C Leavengood, A L Bunker-Soler, H S Nelson.   

Abstract

Because of recent reports linking elevations of serum theophylline levels to toxic ranges with the administration of large doses of hydrocortisone we undertook a study of the effect of high-dose corticosteroids on theophylline blood levels in normal volunteers. Seven volunteers received a sustained-release theophylline preparation every 12 hours until stable blood levels were achieved. Each subject then received during three separate eight-hour testing sessions intravenous boluses of either methyl prednisolone, hydrocortisone or saline. Theophylline levels were obtained hourly. Corticosteroids did not increase serum theophylline levels significantly. In fact, theophylline clearance rates on corticosteroids were 21% higher than on saline, p less than .02.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6838022

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  5 in total

Review 1.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

Review 2.  Adverse reactions and interactions with theophylline.

Authors:  M H Skinner
Journal:  Drug Saf       Date:  1990 Jul-Aug       Impact factor: 5.606

3.  Effect of prednisolone on theophylline pharmacokinetics in patients with chronic airflow obstruction.

Authors:  R J Fergusson; C M Scott; P Rafferty; J Gaddie
Journal:  Thorax       Date:  1987-03       Impact factor: 9.139

4.  Influence of prednisolone on antipyrine elimination in patients with obstructive lung disease.

Authors:  S Loft; K Simonsen; T Evald; H R Christensen; J Sonne; M Døssing
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 5.  Pharmacokinetic drug interactions with theophylline.

Authors:  J H Jonkman; R A Upton
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.